Conjugation and radiolabeling of monoclonal antibodies with zirconium-89 for PET imaging using the bifunctional chelate p-isothiocyanatobenzyl-desferrioxamine

89Zr immuno-PET: comprehensive procedures for the production of 89Zr-labeled monoclonal antibodies.

Iris Verel, Gerard W.M. Visser, Ronald Boellaard et al. · PubMed · 2003 · 370 citations

Pharmacy, Biotechnology, Immunology +17

Development and Characterization of Clinical-Grade ⁸⁹Zr-Trastuzumab for HER2/<i>neu</i> ImmunoPET Imaging

Eli Dijkers, Jos G. W. Kosterink, Anna P. Rademaker et al. · Journal of Nuclear Medicine · 2009 · 337 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

In Vivo VEGF Imaging with Radiolabeled Bevacizumab in a Human Ovarian Tumor Xenograft

Wouter B. Nagengast, Elisabeth G.E. de Vries, Geke A.P. Hospers et al. · Journal of Nuclear Medicine · 2007 · 314 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Improved tumor targeting of anti–epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody technology

Bernard M. Tijink, Toon Laeremans, Marianne Budde et al. · Molecular Cancer Therapeutics · 2008 · 294 citations

Pharmacy, Oncology, Pharmaceutics +17

Performance of Immuno–Positron Emission Tomography with Zirconium-89-Labeled Chimeric Monoclonal Antibody U36 in the Detection of Lymph Node Metastases in Head and Neck Cancer Patients

Pontus K.E. Börjesson, Yvonne W. S. Jauw, Ronald Boellaard et al. · Clinical Cancer Research · 2006 · 238 citations · Full text

Medicine, Nuclear Medicine, Oncology +16